Loss of low-affinity nerve growth factor receptor during malignant transformation of the human prostate

Prostate

Volumn 30, Issue 4, 1997, Pages 274-279

  Perez, Manuel ^a   Regan, Terry ^a   Pflug, Beth ^a   Lynch, John ^a   Djakiew, Daniel ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

carcino genesis; clinically localized prostate adenocarcinoma; loss of LNGFR

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATE SECRETION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BINDING, COMPETITIVE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, NERVE GROWTH FACTOR; REFERENCE VALUES;

EID: 0030940530     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970301)30:4<274::AID-PROS8>3.0.CO;2-L     Document Type: Article

References (17)

1. Harper GP, Barde YA, Burnstock YA, Carstairs JR, Dennison ME, Suda ME, Vernon CA: Guinea pig prostate is a rich source of nerve growth factor. Nature 279:160-163, 1979.
2. Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M: Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res 51:3304-3310, 1991.
3. MacGrogan D, Saint-Andre J-P, Dicou E: Expression of nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J Neurochem 59:1381-1391, 1992.
4. Graham CW, Lynch JH, Djakiew D: Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 147:1444-1447, 1992.
5. Pflug BR, Onoda M, Lynch JH, Djakiew D: Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 52:5403-5406, 1992.
6. Pflug BR, Dionne C, Kaplan DR, Lynch J, Djakiew D: Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 136:262-268, 1995.
7. Rabizadeh S, Oh J, Zhong L, Yang J, Bitler CM, Butcher LL, Bredesen DE: Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-348, 1993.
8. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC: Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143:747-752, 1990.
9. Kramer SA, Spahr J, Brendler BB, Glenn JF, Paulson DF: Experience with Gleason's histopathological grading in prostatic cancer. J Urol 124:223-227, 1980.
10. Sagalowsky AI, Milam H, Reveley LR, Silva FG: Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer. J Urol 128:951-954, 1982.
11. Zincke H, Farrow GM, Myers RP, Benson RC, Furlow WL, Utz PC: Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128:498-501, 1982.
12. Greskovich FL, Johnson DE, Tenney DM, Stephenson RA: Prostate specific antigen in patients with clinical stage C prostate cancer: Relation to lymph node status and grade. J Urol 145: 798-801, 1991.
13. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT: Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 54:6249-6256, 1994.
14. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV: Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55:1002-1005, 1995.
15. Murakami YS, Brothman AR, Leach RJ, White R: Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 55: 3389-3394, 1995.
16. Huebner K, Isobe M, Chao M, Bothwell M, Ross AL, Finan J, Hoxie JA, Sethgal A, Buck CR, Lanahan A, Nowell PC, Koprowski H, Croce CM: The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemia. Proc Natl Acad Sci USA 83:1403-1407, 1986.
17. Djakiew D, Delsite D, Dalal R, Pflug B: The role of the low affinity nerve growth factor receptor and the high affinity Trk receptor in human prostate carcinogenesis. Radiat Oncol Invest 3:333-339, 1996.